Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Quantity SLU-PP-332 Compound Compound CID: 5338394 MF: C18H14N2O2 MW: 290.3 g/mol IUPAC Name: 4-hydroxy-N-[(E)-naphthalen-2-ylmethylideneamino]benzamide SMILES: C1=CC=C2C=C(C=CC2=C1)/C=N/NC(=O)C3=CC=C(C=C3)O InChIKey: RNZIMBFHRXYRLL-XDHOZWIPSA-N InChI: InChI=1S/C18H14N2O2/c21-17-9-7-15(8-10-17)18(22)20-19-12-13-5-6-14-3-1-2-4-16(14)11-13/h1-12,21H,(H,20,22)/b19-12+ Create Date: 2006-02-02 Trusted by Labs
Researchers have not studied the potential benefits of thymosin alpha-1 for people with PsA, but it could be a helpful treatment because of its effects on immunity and inflammation
Breaking Down the Potential Mechanisms This is the core of the issue
AvitaFeb 21, 2025Rated 5 out of 5 stars.VerifiedLife saver This treatment is real cats life saver
Muscle Density and BAC Dont simply look for BAC by weight, in light of only muscle tissue processing alcohol
In peptide therapy, compounding allows pharmacies to create peptide formulations that are: More affordable than brand-name versions Customized to specific dosing needs Available when brand shortages occur Combined with other compounds for enhanced effect The Legal Framework: 503A vs
US$ 27.46
US$ 26.08
US$ 28.63
US$ 26.98
US$ 28.13
